a:5:{s:8:"template";s:9184:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta content="text/html; charset=utf-8" http-equiv="content-type"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed%3A300%2C300i%2C400%2C400i%2C600%2C600i%2C800%2C800i&amp;subset=latin%2Clatin-ext" id="bulk-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}p.has-drop-cap:not(:focus)::first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}p.has-drop-cap:not(:focus)::after{content:"";display:table;clear:both;padding-top:14px} @font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:300;src:local('Roboto Condensed Light Italic'),local('RobotoCondensed-LightItalic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVg2ZhZI2eCN5jzbjEETS9weq8-19eDpCEoY9Nc.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:400;src:local('Roboto Condensed Italic'),local('RobotoCondensed-Italic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVj2ZhZI2eCN5jzbjEETS9weq8-19eLAQM4.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:300;src:local('Roboto Condensed Light'),local('RobotoCondensed-Light'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVi2ZhZI2eCN5jzbjEETS9weq8-33mZGCoYag.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:400;src:local('Roboto Condensed'),local('RobotoCondensed-Regular'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVl2ZhZI2eCN5jzbjEETS9weq8-19y7CA.ttf) format('truetype')} /*! normalize.css v3.0.3 | MIT License | github.com/necolas/normalize.css */html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background-color:transparent}a:active,a:hover{outline:0}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}.text-center{text-align:center}ul{margin-top:0;margin-bottom:10px}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.row{margin-left:-15px;margin-right:-15px}.dropdown{position:relative}.dropdown-toggle:focus{outline:0}.nav{margin-bottom:0;padding-left:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-brand{float:left;padding:15px 15px;font-size:18px;line-height:20px;height:50px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}@media (min-width:768px){.navbar-right{float:right!important;margin-right:-15px}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{content:" ";display:table}.container-fluid:after,.container:after,.nav:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}body,html{overflow-x:hidden}body{font-family:'Roboto Condensed',"Helvetica Neue",helvetica,arial,sans-serif;padding:0;color:#404040;font-weight:400;line-height:1.8;font-size:16px;word-wrap:break-word;overflow-x:hidden}a,a:active,a:focus,a:hover{text-decoration:none;color:#0090ff}ul{padding-left:20px}a:active{border-bottom:none}.page-area{padding-top:70px}@media (min-width:768px){.navbar-nav>li>a{padding-top:25px;padding-bottom:25px;transition:all .5s ease-in-out;-moz-transition:all .5s ease-in-out;-webkit-transition:all .5s ease-in-out;-o-transition:all .5s ease-in-out}#site-navigation .container{padding-left:0;padding-right:0}}@media (max-width:767px){.navbar-nav a:focus,.navbar-nav a:hover{color:#fff!important;background-color:#000!important}.menu-container{width:70%;position:absolute;left:0;height:100vh;transform:translate3d(-100%,0,0);overflow-y:auto;overflow-x:auto;background-color:#fff;top:100%}.navbar-brand{padding-right:55px!important}.page-area{left:0;transform:translate3d(0,0,0);transition:transform .5s ease}.navbar-nav{padding:0;margin:0}.navbar-nav a{font-size:14px;padding:12px 10px!important;margin:0!important;line-height:16px!important;float:left!important;margin:0!important;width:100%;text-transform:none!important;word-wrap:break-word;white-space:normal!important}.navbar-nav li{padding:0!important;margin:0!important}}#site-navigation{min-height:70px}.navbar-nav>li>a{border-bottom:0;text-transform:uppercase}.site-title{margin:0;padding:0;font-size:22px;line-height:28px}p.site-description{font-size:13px;line-height:18px;margin:0;-webkit-transition:all .5s ease;transition:all .5s ease}.site-branding-logo{float:left}.site-branding-logo a{border:none;z-index:9999;position:relative}.navbar-brand{padding:10px 15px;height:auto;z-index:99999;position:relative;z-index:1}.navbar{margin-bottom:0}.main-menu{position:relative}.navbar-fixed-top{position:absolute}#site-navigation{background-color:#fff;-webkit-box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);border:none}#site-navigation,nav a{-webkit-transition:all .3s ease;transition:all .3s ease;color:#000}.footer-credits{border-top:1px solid #ccc;padding:15px;clear:both;margin-top:20px;background-color:#fff}</style>
 </head>
<body class="wp-custom-logo" id="blog">
<div class="main-menu">
<nav class="navbar navbar-default navbar-fixed-top" id="site-navigation">
<div class="container">
<div class="navbar-header">
<div class="site-header">
<div class="site-branding-logo">
<a class="custom-logo-link" href="#" itemprop="url" rel="home"></a> </div>
<div class="site-branding-text navbar-brand">
<p class="site-title"><a href="#" rel="home">{{ keyword }}</a></p>
<p class="site-description">
{{ keyword }}</p>
</div>
</div>
</div>
<div class="menu-container"><ul class="nav navbar-nav navbar-right" id="menu-menu-1"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-72 dropdown" id="menu-item-72"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="Projects">Projects</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-73 dropdown" id="menu-item-73"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="About">About</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-74" id="menu-item-74"><a href="#" title="Contacts">Contacts</a></li>
</ul></div> </div>
</nav>
</div>
<div class="page-area">	
{{ text }}
<br>
<br>
{{ links }}
</div>
<footer class="footer-credits container-fluid row" id="colophon">
<div class="container">
<p class="footer-credits-text text-center">{{ keyword }} 2020</p>
</div>
</footer>
</body>
</html>";s:4:"text";s:10096:"The consensus is, that earnings will be down year-over-year somewhere between 20% and 30%. This information should be considered in addition to, and not as substitutes for, information prepared in accordance with U.S. GAAP. Here’s What Will Replace It. 401(k) money doesn't affect the amount of your Social Security benefits, but it can affect whether they're subject to income tax. The company's results in 2019 included a benefit of $33 million ($25 million, or $0.05 per diluted share, on an after-tax basis) related to its allocation of insurance proceeds received pursuant to a settlement and cost-sharing arrangement for a legacy product-related matter. Includes sales of the company’s peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. All rights reserved. The company is actively recruiting for up to 2,000 additional permanent and temporary employees globally to help bolster production in response to increased product demand. He called bottom of stocks in '09, and recommended AMZN before it soared an extraordinary 1,800%. This release includes forward-looking statements concerning the company's financial results and business development activities and outlook for full-year 2020. Non-GAAP financial measures may enhance an understanding of the company’s operations and may facilitate an analysis of those operations, particularly in evaluating performance from one period to another. For the quarter ended March 31, 2020, operational sales growth excludes the impact of foreign exchange and the company’s recent acquisition of Seprafilm. Constant currency growth is a non-GAAP measure. International sales of approximately $3.2 billion increased 1% on a reported basis, 5% on a constant currency basis and 4% on an operational basis. For the second quarter, net income attributable to Baxter was $246 million, or $0.48 per diluted share, a decline of 20% on a U.S. GAAP (Generally Accepted Accounting Principles) basis. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. For more information on the company’s use of non-GAAP financial measures in this press release, please see the Non-GAAP Financial Measures section of this press release. Special items are excluded because they are highly variable or unusual, and of a size that may substantially affect the company’s reported operations for a period. As the quarter progresses, Baxter may provide additional information regarding its operations as appropriate. * ReWalk Robotics (NASDAQ: RWLK) shares are trading higher potentially as traders circulate an August 27th press release that highlighted the US Court of Appeals dismissed a securities lawsuit against the company. Patients’ journeys inspire our work and drive our commitment. Future events or new information may result in different actual results. For more than 85 years, we’ve been focused on saving and sustaining lives and elevating patient care. (To watch Novak’s track record, click here)Other analysts don’t beg to differ. Includes sales of the company’s continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU). With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. With an average price target of $25.50, the upside potential comes in at 153%. Issued $1.25 billion of long-term debt to further strengthen the company’s balance sheet and provide additional liquidity in light of the global COVID-19 pandemic. PM has taken a different tack in recent year, with a turn toward smokeless tobacco products, marketed as cleaner and less dangerous for users’ health.One sign of this is the company’s partnership with Altria to launch and market iQOS, a heated smokeless tobacco product that will allow users to get nicotine without the pollutants from tobacco smoke. (See PYPD stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. Accordingly, management uses these non-GAAP measures internally in financial planning, to monitor business unit performance, and, in some cases, for purposes of determining incentive compensation. We’re engaging with industry thought leaders to explore how science and innovation advance healthcare. Manufacturing operations have also been modified to limit interactions between employee groups. Gainers   * Chewy (NYSE: CHWY) shares are trading higher. With 3 Buy ratings and no Holds or Sells, the word on the Street is that CBIO is a Strong Buy. Reconciliation of Non-GAAP Financial Measure, Cash flows from operations - continuing operations. This release includes forward-looking statements concerning the company’s financial results and business development activities. Rejoice in Results. This has more than just investors worried, as most hopes for a ‘return to normal’ hang on development of a working vaccine for the novel virus.And earnings season is kicking off. Approximately half of all PFIC patients fall into this category.Looking at data on five-year outcomes with MRX, transplant-free survival was established in seven non-truncating PFIC2 patients who achieved sBA control. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges. Recent share appreciation has brought the stock close to that target.Backing his stance, Molchanov writes, “Enviva benefits from an increasingly broad customer base, and there is high-visibility growth via dropdowns. Free cash flow is a non-GAAP measure. Baxter's first-half 2020 worldwide sales totaled approximately $5.5 billion, an increase of 1% on a reported basis and 3% on both a constant currency and operational basis compared to the same period in 2019. ©Copyright 2020 Baxter. For the quarter and year-to-date periods ended June 30, 2020 and projected full-year 2020, special items include intangible asset amortization and impairment charges, business optimization charges, acquisition and integration expenses, expenses related to European medical devices regulation, and investigation and related costs. Future events or new information may result in different actual results. Total option volume in Nio stock was just under two million with 81% of options trading being calls. House Democrats are still rejecting the $1.8 trillion coronavirus aid and stimulus package put forth by the White House, saying that President Trump’s proposal does not go far enough. Includes sales of the company’s parenteral nutrition (PN) therapies and related products.  Other analysts echo Wilbur’s sentiment. Media Contact  While the pandemic poses continued challenges, our ongoing transformation has strengthened our ability to respond to this global healthcare crisis while advancing our strategic priorities in line with our Mission to Save and Sustain Lives.". "Baxter colleagues worldwide continue to address the urgent needs of patients, clinicians and first responders in the ongoing battle against COVID-19, while bringing our life-sustaining products to all those who depend on us for chronic and acute care," said José (Joe) E. Almeida, chairman and chief executive officer. He assigned a $48 price target, suggesting 140% upside potential. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. At the top line, revenues are down to $121 million. Baxter continues to achieve notable strategic milestones in pursuit of its Mission for patients. Additionally, we recorded a gain of $17 million ($17 million, or $0.03 per diluted share, on an after-tax basis) in 2020 for property we sold in conjunction with our business optimization initiatives. Baxter Reports Second-Quarter 2020 Results Second-quarter revenue of $2.7 billion decreased 4% on a reported basis, 1% on a constant currency basis and 2% on an operational basis 1 Second-quarter U.S. GAAP earnings per share (EPS) of $0.48 declined 20%; adjusted EPS of $0.64 declined 24% We are a community of diverse professionals working together to drive better healthcare options. Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2020. Fastly’s stunning September quarter earnings warning is dragging down shares of other network infrastructure providers. First-quarter revenue of $2.8 billion increased 6% on a reported basis and 8% on both a constant currency and operational basis, First-quarter U.S. GAAP earnings per share (EPS) of $0.64 declined 3 percent; Adjusted EPS of $0.82 increased 9 percent1, Company continues to take rapid action on multiple fronts in response to COVID-19 pandemic. The non-GAAP financial measures include adjusted gross margin, adjusted selling, general and administrative expense, adjusted research and development expense, adjusted other operating income, net, adjusted operating income, adjusted operating margin, adjusted income before income taxes, adjusted income tax expense, adjusted net income, adjusted net income attributable to Baxter stockholders, and adjusted diluted earnings per share, all of which exclude special items, sales growth on a constant currency and operational basis, and free cash flow. ";s:7:"keyword";s:24:"baxter financial results";s:5:"links";s:805:"<a href="http://newdestinychurchpc.com/blog/article.php?tag=Heat-Lightning-6bb478">Heat Lightning</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=true-colors-song-meaning-6bb478">True Colors Song Meaning</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=learning-to-fly-lyrics-6bb478">Learning To Fly Lyrics</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=daniella-alonso-husband-6bb478">Daniella Alonso Husband</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=jazz-jackrabbit-1-6bb478">Jazz Jackrabbit 1</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=afshan-azad-age-6bb478">Afshan Azad Age</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=where-do-avalanches-occur-6bb478">Where Do Avalanches Occur</a>,
";s:7:"expired";i:-1;}